Advantest AI Stock Analysis
Want to see ATEYY full AI Analyst Report?
Advantest (ATEYY) AI Stock Analysis
Advantest
(Other OTC:ATEYY)
The overall score of 78 is driven by a powerful fundamental and strategic outlook that is being temporarily overshadowed by weak market momentum. The company's financial performance is exceptional, with surging revenue, expanding margins, and a rock-solid balance sheet. The earnings call reinforced this strength with raised guidance, accelerating capacity plans, and dominant market share gains. However, the stock's technical picture is deeply negative, with the price in a clear downtrend and momentum indicators at oversold levels, creating a significant divergence between the company's operational reality and its current market price. The high P/E ratio and negligible dividend yield provide no valuation cushion. The score reflects a high-quality company facing strong near-term selling pressure.
Advantest (ATEYY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $118.06B
- Dividend Yield
- 0.12%
- Average Volume (3M)
- 174.17K
- Price to Earnings (P/E)
- 32.8
- Beta (1Y)
- 2.27
- Revenue Growth
- 39.75%
- EPS Growth
- 107.99%
- Country
- US
- Employees
- 7,241
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Semiconductors
Advantest Business Overview & Revenue Model
Company Description
Advantest Corporation is a leading provider of advanced testing equipment for semiconductors and electronic components, in addition to mechatronics-based solutions. The company's operations are divided into three primary divisions: Semiconductor and...
How the Company Makes Money
Advantest primarily makes money by selling automatic test equipment (ATE) systems to semiconductor manufacturers and subcontractors that perform wafer sort and final test in high-volume production. Revenue is generated from (1) system sales of ATE pl...
Advantest Earnings Call Summary
The call was strongly positive overall. Management described very strong results, raised full-year guidance, cited robust demand across GPU, custom ASIC, and CPU testing, and outlined accelerating capacity expansion, market-share gains, and substantial ATE market opportunities. The principal challenges were higher DDR and component costs, expected margin pressure, memory scarcity, and limited disclosure on the timing of future capacity milestones.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management said it originally targeted 10,000 systems by the end of fiscal 2028, but the ramp “has to be accelerated pretty significantly,” with “high confidence” and a time frame likely to be pinpointed “in the next quarter or so”; it expects to ship more systems in Q3 and “even higher systems than in Q4,” with Q4 memory systems “quite strong,” while currency-adjusted first-half to second-half top-line growth is expected to be “28% growth, half-over-half.” ATE TAM CAGR has been “about 50% or a little above 50%,” is not expected to slow, and customer CAGRs are “mid to high 50s all the way through 2029”; CPO testing is expected to see “a double or tripling every year for the next couple of years,” reaching “somewhere in the billion-dollar ATE market size,” versus an overall SoC market “above $11 billion” growing at a “50%+ CAGR.” SoC tester share rose from 56% in 2024 to 66% in 2025, with a path “above 70%,” the “70% threshold” expected “in the near future,” share gains expected in 2026 and 2027, and the 70% market share expected “in the end of fiscal 2026 and the beginning of the fiscal 2027, in other words, April”; annual margins are “settling in at this low 50s,” pricing is expected to remain competitive with no “material impact,” and the next production-capacity step under discussion is “another doubling from 10,000 to 20,000,” with timing not yet disclosed and possible further detail by Mid-Term Plan 4 in the May timeframe.
Advantest Financial Statement Overview
Summary
Exceptional financial health. Revenue growth has surged over 50%, profitability has more than doubled with net margins reaching 37.3%, and the balance sheet is a fortress with a negligible 0.10 debt-to-equity ratio and elite 58.9% return on equity. Cash flow generation is robust and high-quality, with free cash flow growing remarkably.
Income Statement
92Very PositiveBalance Sheet
95Very PositiveCash Flow
90Very Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.46T | 1.20T | 779.71B | 486.51B | 560.19B | 416.90B |
| Gross Profit | 996.46B | 769.90B | 445.08B | 246.03B | 319.06B | 235.91B |
| EBITDA | 758.95B | 526.42B | 257.13B | 108.98B | 189.08B | 129.70B |
| Net Income | 579.54B | 397.99B | 161.18B | 62.29B | 130.40B | 87.30B |
Balance Sheet | ||||||
| Total Assets | 1.74T | 1.18T | 854.21B | 671.23B | 600.22B | 494.70B |
| Cash, Cash Equivalents and Short-Term Investments | 404.25B | 341.44B | 262.54B | 106.70B | 85.54B | 116.58B |
| Total Debt | 107.90B | 20.28B | 93.50B | 94.44B | 50.84B | 43.46B |
| Total Liabilities | 590.54B | 377.72B | 347.67B | 240.05B | 231.53B | 200.07B |
| Stockholders Equity | 1.15T | 799.18B | 506.54B | 431.18B | 368.69B | 294.62B |
Cash Flow | ||||||
| Free Cash Flow | 470.63B | 320.39B | 266.54B | 12.13B | 46.64B | 60.67B |
| Operating Cash Flow | 506.78B | 355.40B | 285.97B | 32.67B | 70.22B | 78.89B |
| Investing Cash Flow | -229.38B | -36.64B | -42.19B | -27.94B | -26.71B | -46.91B |
| Financing Cash Flow | -176.46B | -244.45B | -82.82B | 10.76B | -77.43B | -68.74B |
Advantest Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATEYY, the sentiment is Negative. The current price of 163.32 is below the 20-day moving average (MA) of 202.32, below the 50-day MA of 216.16, and below the 200-day MA of 188.26, indicating a bearish trend. The MACD of -13.41 indicates Positive momentum. The RSI at 36.88 is Neutral, neither overbought nor oversold. The STOCH value of 13.07 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ATEYY.
Advantest Peers Comparison
Overall Rating
ATEYY78Outperform
FORM72Outperform
TER72Outperform
AEHR58Neutral
ONTO58Neutral
COHU54Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | $113.77B | 32.84 | 62.73% | 0.12% | 39.75% | 107.99% | |
| 72Outperform | $6.51B | 37.00 | 15.83% | ― | 29.08% | 320.89% | |
| 72Outperform | $36.56B | 26.58 | 42.04% | 0.22% | 74.93% | 218.54% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 58Neutral | $1.63B | 821.98 | 1.20% | ― | -15.21% | -81.50% | |
| 58Neutral | $9.80B | 64.43 | 7.44% | ― | 30.86% | -13.97% | |
| 54Neutral | $1.91B | -81.98 | -2.90% | ― | 34.00% | 69.09% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ATEYY | Advantest Corp | 163.32 | 38.36 | 30.69% | |
| AEHR | Aehr Test | 49.74 | 29.88 | 150.45% | |
| COHU | Cohu Inc | 40.41 | 18.53 | 84.69% | |
| FORM | Formfactor | 83.03 | 32.62 | 64.69% | |
| ONTO | Onto Innovation | 199.57 | 68.62 | 52.40% | |
| TER | Teradyne | 234.18 | 66.28 | 39.47% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
